Literature DB >> 36070164

Myconanoparticles Break Antibiotic Resistance in Staphylococcus aureus and Acinetobacter baumannii.

S Janarthanan1, S Ranjani1, S Hemalatha2.   

Abstract

In this current study, the extracts of endophytic fungi (Aspergillus niger) were utilized to synthesize the silver nanoparticles (AnNps). In silico screening was carried out by docking secondary metabolites of Aspergillus niger with drug-resistant proteins such as penicillin-binding protein (pbp2a) and clumping factor A of Staphylococcus aureus, penicillin-binding protein (PBP3), and outer membrane protein of Acinetobacter baumannii. The molecular docking analysis revealed the interaction between secondary metabolites of Aspergillus niger with virulence factors of the pathogenic bacteria. AnNps are characterized by various physicochemical methods to determine the size, shape, and stability. Antibacterial efficacy of synthesized nanoparticles (AnNps) was screened in clinical pathogens. AnNp treatment significantly reduced the growth of MDR pathogens. The results suggested that AnNps can be incorporated to produce antimicrobial agents to control drug resistant pathogenic bacteria.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Aspergillus niger; Endophytic fungi; Multidrug-resistant bacteria; Nanotechnology

Year:  2022        PMID: 36070164     DOI: 10.1007/s12010-022-04125-x

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   3.094


  2 in total

1.  Phytocompounds of Onion Target Heat Shock Proteins (HSP70s) to Control Breast Cancer Malignancy.

Authors:  Karunya Jenin Ravindranath; Noorul Samsoon Maharifa Haja Mohaideen; Hemalatha Srinivasan
Journal:  Appl Biochem Biotechnol       Date:  2022-06-06       Impact factor: 3.094

2.  Molecular Docking of Phytochemicals Targeting GFRs as Therapeutic Sites for Cancer: an In Silico Study.

Authors:  Love Edet Mendie; S Hemalatha
Journal:  Appl Biochem Biotechnol       Date:  2022-01-06       Impact factor: 2.926

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.